CorMedix Inc. (CRMD) shares touched 52-week highs in Tuesday's market, the biopharmaceutical company's first day of trading on the Nasdaq. The company's shares were previously listed on the NYSE American.
Stock has moved up significantly. They do await a bid FDA decision at the end of the month, so that's part of it. I do not recommend this stock, as it has run up so much already, just here as an example.